pepmg_

Study summary · research use only

Structure-activity relationships of furazano[3,4-b]pyrazines as mitochondrial uncouplers

Study · Bioorganic & medicinal chemistry letters · 2015 · DOI 10.1016/j.bmcl.2015.06.040 · PMID 26119501

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This study reports a structure-activity relationship investigation of furazanopyrazines as mitochondrial uncouplers. The abstract explains that chemical mitochondrial uncouplers are lipophilic weak acids transporting protons into the mitochondrial matrix independently of ATP synthase, uncoupling nutrient oxidation from ATP production, with potential relevance to obesity, Parkinson's disease and aging. It notes the authors previously identified the protonophore BAM15, which stimulates mitochondrial respiration across a broad dosing range compared with FCCP, and reports investigations showing the importance of the furazan, pyrazine and aniline rings and pKa in maintaining protonophore activity.

Abstract

Chemical mitochondrial uncouplers are lipophilic weak acids that transport protons into the mitochondrial matrix via a pathway that is independent of ATP synthase, thereby uncoupling nutrient oxidation from ATP production. These uncouplers have potential for the treatment of diseases such as obesity, Parkinson's disease, and aging. We have previously identified a novel mitochondrial protonophore, named BAM15, which stimulates mitochondrial respiration across a broad dosing range compared to carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP). Herein, we report our investigations on the structure-activity relationship profile of BAM15. Our studies demonstrate the importance of the furazan, pyrazine, and aniline rings as well as pKa in maintaining its effective protonophore activity.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.